Wednesday, November 08, 2017 12:34:25 PM
As most of you know my biggest concern is any type of delay at this point. This was brought up very recently as far as any general delays and the response was basically, we can't ever rule out delays completely. We can't predict what the future will present us. It was more along the lines of a standard answer. I was hoping for the emphatic NO, but 100% agree with there answer.
Also, FDA/CE Mark submission is still confirmed for end of 2018. So even if there was some sort of delay it hasn't affected there FDA timeline.
I'll be at a conference in San Diego on Monday and Tuesday so I won't be able to listen in. Any chance a few good people on here can throw some bullet points out from the call on Monday?
Thanks...
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM